Compare IHRT & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IHRT | OFIX |
|---|---|---|
| Founded | 1974 | 1987 |
| Country | United States | United States |
| Employees | 9550 | N/A |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.7M | 473.3M |
| IPO Year | N/A | 1998 |
| Metric | IHRT | OFIX |
|---|---|---|
| Price | $3.98 | $12.80 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $4.25 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 561.1K | 228.9K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | $9.96 | $6.10 |
| Revenue Next Year | N/A | $6.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $0.95 | $10.25 |
| 52 Week High | $5.44 | $16.99 |
| Indicator | IHRT | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 74.93 | 61.64 |
| Support Level | $3.62 | $12.33 |
| Resistance Level | $4.00 | $16.38 |
| Average True Range (ATR) | 0.17 | 0.41 |
| MACD | 0.12 | 0.19 |
| Stochastic Oscillator | 95.37 | 88.71 |
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.